Helios Technologies (HLIO) CEO receives RSU, performance option and share grants

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Helios Technologies, Inc. President and CEO Sean Bagan reported equity awards on March 5, 2026. He acquired 18,770 restricted stock units, 38,846 performance stock options and 3,698 shares of common stock at a reported price of $67.61 per share, all held directly.

According to the footnotes, the restricted stock units were approved as a one-time special equity award that vested immediately on March 5, 2026 and were settled in an equal number of common shares on the same date, subject to his continued employment through the vesting date. The performance stock options may deliver up to 225% of the granted amount depending on achievement of pre-established performance metrics over a three-year performance period, with a 10-year term from the grant date.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Bagan Sean

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	18,770	$0.00	--
Grant/Award	Performance Stock Options (right to buy)	38,846	$0.00	--
Grant/Award	Common Stock	3,698	$67.61	$250K

Holdings After Transaction: Restricted Stock Units — 18,770 shares (Direct); Performance Stock Options (right to buy) — 38,846 shares (Direct); Common Stock — 19,632 shares (Direct)

Footnotes (1)

The restricted stock units granted to the reporting person on March 5, 2026, were approved by the Company's Compensation Committee as a one-time special equity award. The award vested immediately upon grant on March 5, 2026, and was settled in shares of the Company's Common Stock on a one-for-one basis on the same date, subject to the reporting person's continued employment through the vesting date. Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029. The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/09/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bagan Sean

(Last)

(First)

(Middle)

C/O HELIOS TECHNOLOGIES, INC.

7456 16TH ST E

(Street)

SARASOTA

34243

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HELIOS TECHNOLOGIES, INC. [ HLIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/05/2026		A		3,698⁽¹⁾	A	$67.61	19,632	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0⁽²⁾	03/05/2026		A		18,770		⁽²⁾	⁽²⁾	Common Stock	18,770	$0	18,770	D
Performance Stock Options (right to buy)	$67.61	03/05/2026		A		38,846		⁽³⁾	⁽³⁾	Common Stock	38,846	$0	38,846	D

Explanation of Responses:

1. The restricted stock units granted to the reporting person on March 5, 2026, were approved by the Company's Compensation Committee as a one-time special equity award. The award vested immediately upon grant on March 5, 2026, and was settled in shares of the Company's Common Stock on a one-for-one basis on the same date, subject to the reporting person's continued employment through the vesting date.

2. Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.

3. The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

	/s/ Marc Greenberg, Attorney-in-fact for Sean Bagan	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Helios (HLIO) CEO Sean Bagan report on March 5, 2026?

Sean Bagan reported equity grants including 18,770 restricted stock units, 38,846 performance stock options and 3,698 shares of common stock. All awards were reported as directly held and were classified as grants or awards rather than open-market purchases or sales.

How were the restricted stock units granted to Helios (HLIO) CEO structured?

The filing states 18,770 restricted stock units were granted as a one-time special equity award. Footnotes explain they vested immediately on March 5, 2026 and were settled into an equal number of Helios common shares that same day, subject to continued employment through the vesting date.

What are the key terms of the Helios (HLIO) CEO performance stock options granted?

The performance stock options cover 38,846 units and can deliver up to 225% of that amount upon vesting. The actual number depends on achieving pre-established performance metrics over a three-year performance period, and the options expire ten years from the March 5, 2026 grant date.

Did Helios (HLIO) CEO Sean Bagan buy or sell shares on the market in this Form 4?

No open-market buying or selling is described. All three transactions are coded as grants or awards, meaning the CEO acquired restricted stock units, performance stock options and common shares as part of compensation arrangements rather than through market purchases or sales.

How many Helios (HLIO) common shares did the CEO directly own after these transactions?

After the March 5, 2026 common stock transaction, the Form 4 reports that Sean Bagan directly owned 19,632 Helios common shares. This figure reflects his direct non-derivative holdings immediately following the reported grant of 3,698 shares.

Are the Helios (HLIO) CEO equity awards tied to performance conditions?

Yes, the performance stock options are contingent on achieving pre-established performance metrics over a three-year period. The filing notes that the number of options ultimately earned can be up to 225% of the granted amount, depending on performance against those metrics.